Announcements - OBI Pharma

2026.May.12

The Company's Board of Directors resolved to convene the 2026 Annual General Shareholders' Meeting (Additional matters)

2026.May.12

The Company’s BOD resolved to terminate the issuing of new common shares by private placement approved by the 2025 Annual General Shareholders’ Meeting

2026.May.12

Announcement pursuant to Article 22.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies

2026.May.12

Announcement of the Company’s BOD resolved to support the over-allotment for TPEx listing of AP Biosciences, Inc.

2026.May.12

Announcement of the Consolidated Financial Statements for the first quarter of 2026 were approved by the Board of Directors

2026.May.07

Announcement on behalf of Amaran that its BOD has elected Dr. Yeong-Fang Chiang to serve as Chairperson of the Board and concurrently as General Manager

2026.May.04

Announcement for the expected date of the Board of Directors Meeting for 2026Q1 consolidated financial report is 2026/05/12

2026.Apr.30

Announcement of the election of Vice Chairperson by the Company’s Board of Directors

2026.Apr.30

Announcement on behalf of Amaran for the change of representative of its institutional director

2026.Apr.30

Announcement of the change of representative of the Company’s institutional director, Yi Tai Investment Co., Ltd.

News

Latest News

Events

Latest events